CHENGDU, China, Jan. 11, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company and HBM Holdings Limited ("Harbour BioMed") (together with the Company, the "Licensors"), have entered into an exclusive license agreement (the...
Read More Details
Finally We wish PressBee provided you with enough information of ( Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb). )
Also on site :
- Even as Israel Blitzes Tehran, It Fears Iran’s Destructive Missiles
- 'ER' Star, 50, Reveals How Maura Tierney Helped Him
- Huge blaze after Israel strikes oil depot in Tehran (VIDEOS)